Antibiotic resistance: How did we get here?
07 October 2019
Finding ways to enlist the bacteria living in our bodies to defend against infections while better understanding their role in promoting antibiotic resistance are key to fighting this growing problem, says Dr Nassos Typas, a microbiologist at the European Molecular Biology Laboratory in Heidelberg, Germany.
Antibiotic resistance is now regarded as one of the largest public health issues to face the world. In Europe alone, an estimated 33,000 people die every year due to infections caused by drug resistant bacteria. By 2050, it could lead to 10 million deaths a year worldwide.
Further reading: Horizon Science Blog
Author(s): Richard Gray
Effective Surveillance
OUR UNDERWRITERS
Unrestricted financial support by:
 |
Antimicrobial Resistance Fighter Coalition |
 |
Evotec |
 |
JSS University |
 |
INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS |
Technology Database
Display your AMR Technology, Product and Service
Suppliers and Users of Technologies, Products and Services benefit from CAPI.
CAPI (Continuous AMR Partnering Initiative) unites Suppliers and Users worldwide with the aim to add to the curbing of AMR.
